Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.88 - $4.8 $8,352 - $13,920
-2,900 Closed
0 $0
Q3 2023

Nov 13, 2023

BUY
$5.07 - $8.44 $14,703 - $24,476
2,900 New
2,900 $15 Million
Q3 2022

Nov 13, 2023

SELL
$6.5 - $12.67 $552 - $1,076
-85 Closed
0 $0
Q4 2021

Nov 13, 2023

BUY
$25.17 - $36.85 $2,139 - $3,132
85 New
85 $2.25 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.12B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.